news.cision.com

AB Nordiska Kompaniet (NK), a subsidiary of Hufvudstaden, has reached an agreement with RNB Retail and Brands AB (RNB) to acquire the NK business within its subsidiary Departments & Stores Europe AB (DSE). DSE currently runs about 40 fashion, cosmetics and jewellery departments at NK Stockholm and NK Gothenburg, together comprising about 25 per cent of the total number of departments in the two stores. DSE generated revenues of SEK 773 million in the 2019/2020 financial year and has about 400 employees, equivalent to 275 full-time annual employees.“The acquisition of DSE’s NK business

Analysguiden announces new research report with the target price for ExpreS2ion at 24 SEK per share

Hørsholm, Denmark, January 27, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that Aktiespararnars’ Analysguiden has published an updated equity research report on ExpreS2ion. The updated sum-of-the-parts valuation base case remains at 24 SEK per share.The major contributors of value in the sum-of-the-parts valuation are the PREVENT-nCoV COVID-19 vaccine program, now designated ABNCoV2 under exclusive license to Bavarian Nordic, and ExpreS[2]ion’s planned exercise of the option to inlicense the AV001/ES2B-C001 breast cancer vaccine candicate from its joint venture

RNB TO SELL DEPARTMENTS & STORES OPERATIONS TO NK

RNB Retail and Brands AB (publ) today announces that it has reached an agreement with NK Retail AB for the sale of the assets of Departments & Stores for a preliminary value of SEK 58 million. RNB Retail and Brands AB has previously announced a process to separate the group subsidiaries and ultimately divest the subsidiaries to stable and suitable owners. One such process has now reached an important milestone with the agreement to divest the assets of Departments & Stores to NK Retail AB. As part of the agreement, all Departments & Stores employees are offered employment with NK Retail

Cereno Scientific strengthens patent protection for Phase II drug candidate CS1 across two patent families

Cereno Scientific today announced that the intellectual property rights (IPR) for drug candidate CS1 have been expanded in two different patent families. The patent granted in Canada belongs to the company’s first patent family, and the patent granted in Russia belongs to the company’s second patent family. This is a result of Cereno’s continuous work in securing IPR for its assets to strengthen the commercial positioning.“Working to continuously strengthen our IPR around our drug candidates and technology is an important part of our strategy aimed at optimally positioning Cereno for

Beijer Ref acquires Australian HVAC Distributor

The global refrigeration wholesaler Beijer Ref has signed an agreement to acquire all the shares in the Australian distribution company Complete Air Supply.Complete Air Supply (CAS) is a leading manufacturer and distributor of ducting and associated fittings within air conditioning in Australia with around 40 employees. Sales are made through a distribution network of three branches in Queensland. Annual sales amount to approximately SEK 130 million. Beijer Ref acquires CAS from one main principal owner. Beijer Ref is already present in Australia through Beijer Ref Australia, Kirby and ACD

Crunchfish launches partner strategy for Digital Cash

An ecosystem for Digital Cash Partners will be very important in the commercialization of Crunchfish’s Digital Cash solutions. By cooperating with partners within complementing fields of technology, Crunchfish opens up marketing channels, new geographical markets and strategic customer segments. With some partners already in place, Crunchfish now defines an ecosystem for Digital Cash with the purpose to quickly scale up sales and get a global spread of the company’s solutions.Crunchfish’s Digital

Invitation to DNB’s extended fourth quarter presentation, Wednesday, 10 February 2021

DNB will publish its results for the fourth quarter of 2020 on Wednesday, 10 February 2021 at 07.30 CET. The fourth quarter results will be presented at 9:30-11:30 CET the same day, at an extended presentation which will also include an update on dividends, strategic topics, status on financial ambitions, and presentations from the customer segments. The event will be webcasted, and it will be possible to ask questions online. Link to webcast will be made available at ir.dnb.no. Agenda: · Kjerstin Braathen (CEO) · Ottar Ertzeid (CFO) · Harald Serck-Hanssen (Group EVP

New US patent approval for Episurf Medical

Wed, Jan 27, 2021 08:14 CET

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Design of an implant for cartilage repair”, relates to Episurf Medical’s design processes for individualised design and has a focus on a surgical instrument for inserting the company’s Episealer® implants accurately. “This is the first approval in this patent family, giving us protection in the area of individualised design of surgical devices. Through our design processes we create medical devices with the best possible fit for each

Recently opened restaurant in Oslo invests in environmentally friendly solutions together with Kiilto

The past 12 months have been a tough for the restaurant industry. However, Brasilia opened its new grill restaurant in Oslo, Norway on December 1 and takes hygiene and infection control very seriously during the on-going COVID-19 pandemic. Brasilia, which also has a restaurant in Bergen, has chosen Kiilto as the total supplier of cleaning and disinfectant products from the brands Kiilto Pro and Antibac.The world's best restaurants have an impeccably clean kitchen. It is an indicator of the restaurant’s food standards and shows that the restaurant's staff values high quality in their work.

Norway Royal Salmon (NRS): Selected preliminary Q4 figures for Arctic Fish ehf.

Wed, Jan 27, 2021 08:02 CET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Arctic Fish ehf ("Arctic Fish"), a company owned 50 % by Norway Royal Salmon (NRS), harvested 2 988 tonnes (HOG) during the fourth quarter of 2020, resulting in a total harvest of 7 443 tonnes (HOG) for 2020. Arctic Fish expects to harvest

Adverty and Verizon Media announce new deal to enable a huge range of brands and audiences to access Adverty’s innovative ad formats within gaming

Wed, Jan 27, 2021 08:02 CET

Adverty AB (publ) today announces a new deal with global media and technology company Verizon Media, a division of Verizon Communications Inc., which houses a trusted media ecosystem of premium brands and industry-leading technology platforms. The integration of Adverty’s platform will enable Verizon Media’s wide range of advertisers and audiences to access Adverty’s seamless ad inventory at scale.Adverty will connect to Verizon Media’s Sell-Side Platform (SSP), enabling its unique and unobtrusive ad offering to reach wider audiences within gameplay, to maximise brand exposure and publisher

AKER ASA: Aker Horizons, Aker Offshore Wind enter cooperation agreement with Statkraft

Aker ASA (“Aker”) today announced that its wholly owned subsidiary, Aker Horizons AS (“Aker Horizons”), and Aker Offshore Wind Operating Company AS (“Aker Offshore Wind”) have entered into a cooperation agreement with Statkraft AS (“Statkraft”) to explore possibilities for collaboration on offshore wind power projects on the Norwegian Continental Shelf (“NCS”).Aker Horizons, Aker Offshore Wind and Statkraft (the “Parties”) will work together and utilize their complementary skills and expertise to explore the possibility to develop and operate large-scale offshore wind parks in Norway. By

AKER ASA: Aker Horizons strengthens renewables portfolio with entry into hydropower

Aker ASA (“Aker”) announced today that its wholly owned subsidiary Aker Horizons AS (“Aker Horizons”) has entered into an agreement to acquire Rainpower Holding AS (“Rainpower”). Aker Horizons will use Rainpower as a platform to build a next generation technology company to optimize hydropower developments and operations.“Aker Horizons is continuing its planet-positive investing, making strides towards developing a growth platform of integrated renewable technologies with positions in onshore and offshore wind and solar. With increasing demand for power market flexibility and storage

YIT becomes a service operator for business premises

The first Workery+ will open in Vallila in the spring with the aim of creating a network of business premises in the Helsinki metropolitan area. The new situation caused by the COVID-19 pandemic has prompted companies to consider how the ways of working will be reshaped once the worst is over. Can any company predict how much space they need now that remote working is here to stay? YIT is introducing a new concept called Workery+ to the business premises market, combining best practices from both traditional office rental and coworking spaces. “Our first location in Vallila,

NENT Group tops Nordic Business Diversity Index

· NENT Group ranked number one in Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories · Nordic Business Diversity Index measures diversity of boards and executive management · NENT Group has a 50/50 gender split in senior leaders reporting to CEO Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has been ranked number one in the Nordic Business Diversity Index in both the Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories. The Nordic Business Diversity Index measures the diversity of boards and executive

BioArctic receives European patent for new antibodies targeting Alzheimer’s disease

Stockholm, January 27, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for novel antibodies that could be developed into a treatment for Alzheimer’s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aβ) and are linked to the company’s project AD1503. The patent enters into force on 27 January 2021 and expires in 2030. BioArctic’s newly granted patent focuses on novel antibodies which target pE3-Ab, a specific truncated form of amyloid

Proposal regarding the Board of Directors

Castellum has received a proposal regarding the composition of the Board of Directors from Stichting Pensioenfonds ABP, the second largest shareholder in Castellum, and two members of the Election Committee, Vincent Fokke, representing Stichting Pensioenfonds ABP, and Charlotte Strömberg, Chair of the Board of Castellum. The election of the Board of Directors will take place at the Annual General Meeting to be held on March 25, 2021.Proposal regarding the composition of the Board The purpose of this proposal is to ensure a Board of Directors of Castellum that is both competent and

SBB increases focus on housing for the elderly

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) intends to double the value of properties for housing for the elderly in the Nordic region within two years to approximately SEK 20 billion. In the current property portfolio, the Swedish tenants are 75 per cent public actors with an average lease period of just over seven years. As part of the acquisition of Sveafastigheter, Magnus Edlund will transfer to SBB in a new role as Head of Business Development for Elderly Care Housing. Magnus has over 30 years of experience from the real estate industry in senior positions with institutional

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 27 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Orexo strengthens IP rights for overdose rescue drug OX124

· Patent protection until 2039 · Previous human pharmacokinetic (PK) study showed significantly better PK profile when compared to market leading product Uppsala, Sweden – January 27, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has further strengthened the intellectual property (IP) for its flagship pharmaceutical pipeline asset OX124, a naloxone rescue medication for the treatment of opioid overdose. The US Patent and Trademark Office (USPTO) has issued a new patent protecting the product until 2039. The new patent, US 10,898,480, is the

Hansa Biopharma to host conference call to provide Year-End report 2020 and Business Update

Lund, Sweden January 27, 2021. Hansa Biopharma will publish its Year-End report 2020 at 8:00 CET on February 4, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/2:00pm EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made

Increased sales and profitability in 2020 during a challenging fourth quarter